Gene therapies need new development models
Wednesday, October 3, 2012 - 07:31
in Health & Medicine
As with other medicines, the approval of gene therapies should hinge on a risk–benefit analysis for the patient, argues Fulvio Mavilio.Nature 490 7 doi: 10.1038/490007a